Deep brain stimulation at the basolateral amygdala alters whole-brain connectivity and synchronization and social behaviors of Tbr1 deficient mice
Tsan‐Ting HsuiD, Tzyy‐Nan HuangiD, Chien-Yao WangiD, Yi‐Ping HsuehiD
Abstract
Autism spectrum disorders (ASD) are considered neural dysconnectivity syndromes. To better understand ASD and uncover potential treatments, it is imperative to know and dissect the connectivity deficits under conditions of autism. Here, we apply a whole-brain immunostaining and quantification platform to demonstrate impaired structural and functional connectivity and aberrant whole-brain synchronization in a Tbr1+/- autism mouse model. We express a channelrhodopsin variant oChIEF fused with Citrine at the basolateral amygdala (BLA) to outline the axonal projections of BLA neurons. By activating the BLA under blue light theta-burst stimulation (TBS), we then evaluate the effect of BLA activation on C-FOS expression at a whole brain level to represent neural activity. We show that Tbr1 haploinsufficiency almost completely disrupts contralateral BLA axonal projections and results in mistargeting in both ipsilateral and contralateral hemispheres, thereby globally altering BLA functional connectivity. Based on correlated C-FOS expression among brain regions, we further show that Tbr1 deficiency severely disrupts whole-brain synchronization in the absence of salient stimulation. Tbr1+/- and wild-type (WT) mice exhibit opposing responses to TBS-induced amygdalar activation, reducing synchronization in WT mice but enhancing it in Tbr1+/- mice. Whole-brain modular organization and inter-module connectivity are also affected by Tbr1 deficiency and amygdalar activation. Following BLA activation by TBS, the synchronizations of the whole brain and the default mode network, a specific subnetwork highly relevant to ASD, are enhanced in Tbr1+/- mice, implying a potential ameliorating effect of amygdalar stimulation on brain function. Indeed, TBS-mediated BLA activation increases nose-to-nose social interactions of Tbr1+/- mice, strengthening evidence for the role of amygdalar connectivity in social behaviors. Our high-resolution analytical platform reveals the inter- and intra-hemispheric connectopathies arising from ASD. Our study emphasizes the defective synchronization at a whole-brain scale caused by Tbr1 deficiency and implies a potential beneficial effect of deep brain stimulation at the amygdala for TBR1-linked autism.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 9
- FWCI
- 2.18
- Field percentile
- top 13%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Abnormal synaptic proteomes, impaired neural ensembles, and defective behaviors in autism mouse models are ameliorated by dietary intervention with nutrient mixtures
Tzyy‐Nan Huang, Ming-Hui Lin, … Yi‐Ping Hsueh·bioRxiv·May 29, 2025
- Loss of the autism associated gene Tbr1 disrupts prediction and encoding by prefrontal ensembles during socioemotional behaviors
Marc Turner, Sarah Robinson Schwartz, … Vikaas Singh Sohal·bioRxiv·Jan 21, 2025
- Altered meningeal immunity contributing to the autism-like behavior of BTBR T+ Itpr3tf/J mice.
D. A. Lawrence, M. N. Uddin, K. Manley·bioRxiv·Jan 29, 2022
- The mirror neuron system compensates for amygdala dysfunction-associated social deficits in individuals with higher autistic traits
Lei Xu, Xiaoxiao Zheng, … Keith Maurice Kendrick·NeuroImagePeer-reviewed·Feb 16, 2022
- Maturation of Nucleus Accumbens Synaptic Transmission Signals a Critical Period for the Rescue of Social Deficits in a Mouse Model of Autism Spectrum Disorder
Melina Matthiesen, Abdessattar Khlaifia, … Maithé Arruda-Carvalho·Molecular BrainPeer-reviewed·May 24, 2023
- Chronic sodium bromide treatment relieves autistic-like behavioral deficits in three mouse models of autism
Cécile Derieux, Audrey Léauté, … Jérôme A. J. Becker·NeuropsychopharmacologyPeer-reviewed·Apr 13, 2022